Efrat Assa - Dec 15, 2021 Form 3 Insider Report for Orgenesis Inc. (ORGS)

Role
Chief Development Officer
Signature
/s/ Efrat Assa Kunik
Stock symbol
ORGS
Transactions as of
Dec 15, 2021
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 05:10 AM
Next filing
Jun 16, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ORGS Stock Option Dec 15, 2021 Common Stock 16.7K $4.80 Direct F1
holding ORGS Stock Option Dec 15, 2021 Common Stock 15K $5.99 Direct F2
holding ORGS Stock Option Dec 15, 2021 Common Stock 15K $2.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options are fully vested.
F2 These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a four-year period, beginning October 22, 2018.
F3 These options were awarded under the Issuer's 2017 Equity Incentive Plan to purchase shares of common stock of the Issuer and vest in equal quarterly installments over a two-year period, beginning March 31, 2020.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney